CCNT2 (cyclin T2) is a transcription coactivator that regulates RNA polymerase II-mediated transcription and plays pleiotropic roles in cellular function and disease. As the regulatory subunit of positive transcription elongation factor b (P-TEFb), CCNT2 promotes transcriptional activation of early and late herpes simplex virus 1 promoters 1. In normal physiology, CCNT2 expression is inversely altered in response to nicotine and its withdrawal in hypothalamic tissue, potentially linking it to weight regulation mechanisms 2. CCNT2 plays a crucial developmental role in adipose tissue programming; reduced CCNT2 expression in adipose-derived stem cells from low birthweight individuals decreases leptin secretion and impairs expression of adipogenic genes including PPARG, LEP, and ADIPOQ 3. CCNT2 is implicated in multiple cancers through competing endogenous RNA networks: in laryngeal papilloma, lncRNA NEAT1 upregulates CCNT2 via sponging miR-577 and miR-1224-5p to promote cell proliferation and block apoptosis 1, while in hepatocellular carcinoma, circROBO1 upregulates CCNT2 by sequestering miR-130a-5p 4. In acute myeloid leukemia and osteosarcoma, miR-192 and miR-188-5p respectively suppress CCNT2 to inhibit cell proliferation and induce cell cycle arrest 56. In oligodendrocyte development, miR-297c-5p targeting CCNT2 promotes myelin-forming cell maturation 7. Genome-wide association studies identify CCNT2 as a BMI-associated gene 8, underscoring its metabolic significance.